Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific
- PMID: 36897291
- PMCID: PMC10464844
- DOI: 10.1002/ana.26637
Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific
Conflict of interest statement
Potential Conflicts of Interest
Nothing to report.
Figures
Comment in
-
Reply to: "Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific".Ann Neurol. 2023 May;93(5):1049. doi: 10.1002/ana.26639. Epub 2023 Mar 21. Ann Neurol. 2023. PMID: 36897272 No abstract available.
Comment on
-
Association of Presynaptic Loss with Alzheimer's Disease and Cognitive Decline.Ann Neurol. 2022 Dec;92(6):1001-1015. doi: 10.1002/ana.26492. Epub 2022 Sep 15. Ann Neurol. 2022. PMID: 36056679
References
-
- Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 1991;41:479–486. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AG046152/AG/NIA NIH HHS/United States
- R01 AG019771/AG/NIA NIH HHS/United States
- R37 MH057881/MH/NIMH NIH HHS/United States
- U01 AG061356/AG/NIA NIH HHS/United States
- U19 AG074879/AG/NIA NIH HHS/United States
- U01 AG068057/AG/NIA NIH HHS/United States
- R01 AG017917/AG/NIA NIH HHS/United States
- R01 LM011360/LM/NLM NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- R01 LM012535/LM/NLM NIH HHS/United States
- P30 AG072976/AG/NIA NIH HHS/United States
- R01 AG015819/AG/NIA NIH HHS/United States
- P30 AG072975/AG/NIA NIH HHS/United States
- R01 MH123184/MH/NIMH NIH HHS/United States
- U01 AG072177/AG/NIA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
